Healthcare company-building profile
Novo Nordisk Golden Ticket at LabCentral
Novo Nordisk with LabCentral
AcceleratorPharma acceleratorCorporateActive
Source-based profile
Program at a Glance
- Program type
- Accelerator
- Program category
- Pharma accelerator
- Organization
- Novo Nordisk with LabCentral
- Organization type
- Corporate
- Location
- Cambridge, Massachusetts
- Company stage served
- Research or idea stage to Early stage
- Cohort or participation model
- One-year LabCentral residency fellowship awarded via annual competition
- Investment or funding offered
- Not publicly documented
- Published investment terms
- Sponsored LabCentral lab space; no equity reported
- Equity or fee model
- No equity
- Clinical or hospital connection
- Not publicly documented
- Application status
- Active
Public description
About the program
Novo Nordisk sponsors a Golden Ticket at LabCentral, offering an early-stage life science startup sponsored residency in the Kendall Square shared laboratory alongside access to Novo Nordisk research teams. LabCentral runs an annual application deadline for the Novo Nordisk award. It is Novo Nordisk's most visible structured US startup residency program.
What the program publicly emphasizes
Focus areas and features
Cardiometabolic diseaseObesity and diabetesBiotech and therapeuticsWet-lab residency
- Category: Pharma accelerator
- Program structure: One-year LabCentral residency fellowship awarded via annual competition
- Published terms: Sponsored LabCentral lab space; no equity reported
Sources
External source links open in a new tab.